Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 44 P38 | DOI: 10.1530/endoabs.44.P38

SFEBES2016 Poster Presentations Adrenal and Steroids (41 abstracts)

18F-FDG PET-CT combined with 11C-metomidate PET-CT for the successful characterisation of adrenal lesions; proof of utility of a novel imaging strategy in guiding management

Andrew S Powlson 1 , Olympia Koulouri 1 , HK Cheow 2 & Mark Gurnell 1

1Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; 2Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK.

Background/aims/method: Evaluation/management of adrenal incidentalomas (AI) is an increasingly prevalent challenge. CT/MRI characteristics may be useful in determining whether a lesion is a benign adenoma and forthcoming ESE-ENSAT guidance suggests a role for 18F-FDG-PET/CT in distinguishing benign vs malignant lesions. We have previously demonstrated the utility of 11C-metomidate (MTO), which binds CYP11B1/B2, in localising aldosterone-producing adenomas. A proposed European study (FAMIAN) suggests combining 18F-FDG-PET/CT with 131-iodometomidate imaging to distinguish tissue of adrenocortical origin as well as malignancy. In support of this hypothesis, we have used this dual imaging approach, with 11C-MTO-PET/CT in conjunction with 18F-FDG-PET/CT, to investigate three patients with indeterminate adrenal pathology.

Results: (1) Double negative MTO and FDG in a benign ganglioneuroma. A 66-year-old woman presented with a non-functioning right AI (40 mm, heterogeneous features on CT, Fig. 1A), which was neither avid for FDG (1B) nor MTO (1C). She elected to have surgery; a benign ganglioneuroma (non-adrenocortical) was confirmed by histology.

(2) Double positive MTO and FDG in metastatic adrenocortical carcinoma (ACC). A 65-year-old woman with a history of right adrenalectomy (ACC) and liver lobectomy (solitary ACC metastasis) ten years previously, presented with tissue in the right adrenal bed/liver. This was avid for both FDG (suggesting malignancy, Fig. 2A) and MTO (suggesting adrenocortical origin, 2B). The diagnosis of recurrent ACC was supported.

(3) Positive FDG and negative MTO in primary adrenal lymphoma. A 66-year-old man presented with a non-functioning 30 mm right AI with indeterminate CT characteristics (baseline Hounsfield Units 40, Fig. 3A) which was FDG-avid (3B) but MTO-negative, with the adjacent normal adrenal showing physiological MTO uptake (3C). Histology demonstrated a rare primary adrenal lymphoma (non-adrenocortical).

Conclusions: Combining FDG and metomidate PET-CT can distinguish benign from malignant adrenal lesions and determine whether they are of adrenocortical origin. This novel approach may thus inform management in cases of indeterminate adrenal pathology.

Volume 44

Society for Endocrinology BES 2016

Brighton, UK
07 Nov 2016 - 09 Nov 2016

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.